Montelukast Sodium Tablet, Film Coated
Product Images NDC 68071-5278

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 68071-5278). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

68071 5278 3

Montelukast Sodium 10 mg tablets film-coated, packaged in a 30-count container from NuCare Pharmaceuticals, Inc. The label includes NDC 68071-5278-3 and product number R1529030. It displays manufacturer information, storage instructions at 68-77°F, and warnings to keep out of reach of children, along with a bar code and QR code for identification.*

FDA Label Image

Figure 1 (Ab6952c2 56b5 4d87 A94b 15c9c39a3ab4 01)

A line graph showing change in height (cm) over weeks on treatment for montelukast sodium 5 mg, beclomethasone 336 mcg, and placebo groups. The x-axis represents weeks on treatment from -19 to 56, and the y-axis depicts height change from -3 to 7 cm. Lines indicate trends in growth change for each group over time.*

FDA Label Image

Structure (Ab6952c2 56b5 4d87 A94b 15c9c39a3ab4 02)

Chemical structure of montelukast sodium displayed as a 2D molecular diagram showing characteristic rings and functional groups including a sodium salt moiety and chlorine substitution.*

FDA Label Image

Figure 2 (Ab6952c2 56b5 4d87 A94b 15c9c39a3ab4 03)

A line graph depicting mean percent change from baseline over 15 weeks in treatment with Montelukast Sodium 10 mg tablets compared to placebo. The x-axis shows weeks in treatment from 0 to 15, including a washout period from week 12 to 15. Data points for Montelukast Sodium are shown as filled circles with a higher increase than placebo, indicated by open squares, throughout the treatment period.*

FDA Label Image

Image (Ab6952c2 56b5 4d87 A94b 15c9c39a3ab4 907 2)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.